Skip to content
AnalystLens

Idex Annual Report, Year Ended Dec 31, 2003

Filing Date
Filed March 5, 2004
Period End
December 31, 2003
Security
IEX
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. FY2016 annual report10-K · Feb ’17Feb ’17
  2. Material agreement8-K · Jun ’19Jun ’19
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 10-K filed March 5, 2004. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation reported record orders, sales, and cash flows for 2003, with net sales of $797.9 milliona, up from $742.0 million in 2002, and net income of $62.4 million, or $1.87 per diluted share, compared with $54.1 million, or $1.67 per share, a year earlier.

Operating income rose to $109.9 millionb from $100.4 million, with operating margin of 13.8% versus 13.5%. Management attributed the gains to higher gross profit from global sourcing and Six Sigma, Kaizen and Lean initiatives, partly offset by higher SG&A expenses. Acquisitions contributed about 2 percentage points of sales growth and foreign currency translation about 5 percentage points, while base business sales rose 1%.

The company operates three segments: Pump Products (57% of 2003 sales and 55% of operating income), Dispensing Equipment (20% of both), and Other Engineered Products (23% of sales and 25% of operating income). Total debt fell to $176.5 millionc at year end from $241.1 million in 2002, and shareholders' equity rose to $592.1 million. Cash flow from operations was $111.7 million, and the filing states that the company expects sufficient cash flow to meet its needs over the next 12 months and the long term.

The company also completed the Sponsler and Classic Engineering acquisitions in 2003 and agreed to acquire Manfred Vetter GmbH in January 2004. The filing discloses asbestos-related lawsuits naming IDEX and nine subsidiaries, which the company states are largely covered by insurance and not expected to have a material adverse effect. Management also noted that 2003 SG&A rose to 25.0%d of sales from 24.4%, and that the Pump Products Group's operating margin declined to 15.4% from 16.5%.

Key Highlights

  1. Net sales of $797.9 million in 2003, up from $742.0 million in 2002; orders of $797.8 million, 6% higher than 2002
  2. Net income of $62.4 million, or $1.87 per diluted share, versus $54.1 million, or $1.67 per diluted share, in 2002
  3. Operating income of $109.9 million with a 13.8% operating margin, compared with $100.4 million and 13.5% in 2002
  4. Total debt reduced to $176.5 million at December 31, 2003, from $241.1 million a year earlier; shareholders' equity increased to $592.1 million
  5. Gross profit margin improved to 38.8% from 37.9%, reflecting lower material costs from global sourcing and operational excellence initiatives
  6. International sales were 45% of 2003 total sales, up from 41% in 2002
  7. Asbestos-related lawsuits against IDEX and nine subsidiaries are largely covered by insurance, and management does not believe they will have a material adverse effect

Frequently Asked Questions

  1. What drove IDEX's earnings growth in 2003?

    Earnings rose mainly because gross profit increased by $27.9 million, driven by reduced material costs from global sourcing and savings from Six Sigma, Kaizen and Lean Manufacturing. Operating income grew $9.5 million, partly offset by higher SG&A expenses, which rose to $199.5 million from $181.3 million.

  2. How much of the sales growth came from acquisitions versus organic growth?

    Management stated that acquisitions contributed 2% and foreign currency translation 5% to sales growth, while base business sales rose 1%. Excluding acquisitions and currency effects, orders were essentially unchanged from 2002.

  3. Which business segment is the largest contributor?

    The Pump Products Group is the largest, accounting for 57% of 2003 sales and 55% of operating income, with sales of $456.5 million. Its operating margin declined to 15.4% from 16.5% in 2002, which management attributed to new product development, additional sales and marketing resources, ERP implementation and reduced volume in some businesses.

  4. How is IDEX's debt position and liquidity?

    Total debt fell to $176.5 million at December 31, 2003, from $241.1 million, and the current ratio was 1.9. The company has a $300 million revolving credit facility, of which $14.0 million was borrowed at year end, and $150 million of 6.875% Senior Notes due February 2008.

  5. What legal risks does the filing disclose?

    IDEX and nine subsidiaries are defendants in asbestos-related personal injury lawsuits, alleging exposure to components supplied by third parties. Settlements and legal costs have been largely covered by insurance, though the company cannot predict future insurance coverage. No provision has been made in the financial statements, and management does not currently believe the claims will have a material adverse effect.